CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | vancomycin |
|
Accession: | CHEBI:28001
|
browse the term
|
Definition: | A complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile. |
Synonyms: | exact_synonym: | (3S,6R,7R,11R,23S,26S,30aS,36R,38aR)-44-[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-3-(carbamoylmethyl)-10,19-dichloro-2,3,4,5,6,7,23,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-(N-methyl-D-leucyl)-2,5,24,38,39-pentaoxo-1H,22H-23,36-(epiminomethano)-8,11:18,21-dietheno-13,16:31,35-di(metheno)[1,6,9]oxadiazacyclohexadecino[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic acid |
| related_synonym: | (1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid; (2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):C(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]; Formula=C66H75Cl2N9O24; InChI=1S/C66H75Cl2N9O24/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95)/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-/m0/s1; InChIKey=MYPYJXKWCTUITO-LYRMYLQWSA-N; SMILES=CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](NC5=O)C(O)=O)c3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)c(Cl)c2; Vancocin; vancomicin; vancomicina; vancomycine; vancomycinum |
| alt_id: | CHEBI:27276; CHEBI:49941; CHEBI:9931 |
| xref: | Beilstein:3132; CAS:1404-90-6; DrugBank:DB00512; Drug_Central:2807; KEGG:C06689; KEGG:D00212; KNApSAcK:C00016052 |
| xref_mesh: | MESH:D014640 |
| xref: | MetaCyc:CPD-12245; PDBeChem:VAN; PMID:11028184; PMID:11408222; PMID:11688538; PMID:11864951; PMID:11886013; PMID:11980329; PMID:12019070; PMID:12541895; PMID:12852813; PMID:13370625; PMID:13521912; PMID:14605050; PMID:14702667; PMID:15047516; PMID:15081082; PMID:15465645; PMID:15590714; PMID:15792257; PMID:16183423; PMID:16184232; PMID:16420976; PMID:16596002; PMID:16720708; PMID:17027219; PMID:17184835; PMID:17299012; PMID:17594206; PMID:18030187; PMID:18159039; PMID:18162343; PMID:18260149; PMID:18361944; PMID:18462092; PMID:18582342; PMID:18817166; PMID:18983037; PMID:19107100; PMID:19830166; PMID:20956604; PMID:21109901; PMID:21458937; PMID:21466775; PMID:21664803; PMID:21719238; PMID:21951032; PMID:22011388; PMID:22015328; PMID:22027450; PMID:22124537; Patent:US3067099; Reaxys:3132; Wikipedia:Vancomycin |
| cyclic_relationship: | is_conjugate_base_of CHEBI:76842 |
|
|
|
G |
A2m |
alpha-2-macroglobulin |
increases expression |
EXP |
Vancomycin results in increased expression of A2M mRNA |
CTD |
PMID:18289764 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aadac |
arylacetamide deacetylase |
increases expression |
ISO |
Vancomycin results in increased expression of AADAC mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734
|
|
G |
Aadat |
aminoadipate aminotransferase |
increases expression |
ISO |
Vancomycin results in increased expression of AADAT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:29,509,392...29,544,332
Ensembl chr16:29,509,394...29,544,332
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
increases expression |
ISO |
Vancomycin results in increased expression of AASS mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
increases expression |
ISO |
Vancomycin results in increased expression of ABAT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ABCA1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abca13 |
ATP binding cassette subfamily A member 13 |
increases expression |
ISO |
Vancomycin results in increased expression of ABCA13 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:83,873,397...84,376,138
Ensembl chr14:83,873,940...84,375,075
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions |
ISO |
[Vancomycin co-treated with Imipenem] results in increased expression of ABCB11 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions increases expression decreases expression |
ISO EXP |
[Vancomycin co-treated with Imipenem] results in decreased expression of ABCB1A mRNA Vancomycin results in increased expression of ABCB1A mRNA Cilastatin inhibits the reaction [Vancomycin results in decreased expression of and affects the localization of ABCB1 protein]; Vancomycin results in decreased expression of and affects the localization of ABCB1 protein Vancomycin results in decreased expression of ABCB1A mRNA; Vancomycin results in decreased expression of ABCB1A protein JBP 485 inhibits the reaction [Vancomycin results in decreased expression of ABCB1A mRNA]; JBP 485 inhibits the reaction [Vancomycin results in decreased expression of ABCB1A protein] |
CTD |
PMID:18930951 PMID:24657338 PMID:28549670 PMID:29964132 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
increases expression |
ISO |
Vancomycin results in increased expression of ABCB1B mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions decreases expression |
ISO EXP |
[Vancomycin co-treated with Imipenem] affects the expression of ABCC2 mRNA Vancomycin results in decreased expression of ABCC2 mRNA; Vancomycin results in decreased expression of ABCC2 protein JBP 485 inhibits the reaction [Vancomycin results in decreased expression of ABCC2 mRNA]; JBP 485 inhibits the reaction [Vancomycin results in decreased expression of ABCC2 protein] |
CTD |
PMID:24657338 PMID:29964132 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions |
ISO |
[Vancomycin co-treated with Imipenem] results in decreased expression of ABCC3 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcd4 |
ATP binding cassette subfamily D member 4 |
increases expression |
ISO |
Vancomycin results in increased expression of ABCD4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:104,246,459...104,260,965
Ensembl chr 6:104,246,468...104,280,276
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
multiple interactions |
ISO |
[Vancomycin co-treated with Imipenem] affects the expression of ABCG5 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
multiple interactions |
ISO |
[Vancomycin co-treated with Imipenem] affects the expression of ABCG8 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Abhd1 |
abhydrolase domain containing 1 |
increases expression |
ISO |
Vancomycin results in increased expression of ABHD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
|
|
G |
Abhd14a |
abhydrolase domain containing 14A |
increases expression |
ISO |
Vancomycin results in increased expression of ABHD14A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:107,079,139...107,089,004
Ensembl chr 8:107,079,144...107,086,985
|
|
G |
Abhd3 |
abhydrolase domain containing 3, phospholipase |
increases expression |
ISO |
Vancomycin results in increased expression of ABHD3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:1,723,203...1,778,488
Ensembl chr18:1,720,718...1,803,428
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of ACAA2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions |
ISO |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of ACACA mRNA |
CTD |
PMID:34979169 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acad10 |
acyl-CoA dehydrogenase family, member 10 |
increases expression |
ISO |
Vancomycin results in increased expression of ACAD10 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:34,901,211...34,943,973
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
increases expression |
ISO |
Vancomycin results in increased expression of ACAD9 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
|
|
G |
Acadsb |
acyl-CoA dehydrogenase, short/branched chain |
increases expression |
ISO |
Vancomycin results in increased expression of ACADSB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:186,188,939...186,227,796
Ensembl chr 1:186,188,987...186,230,379
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of ACAT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACAT2 protein |
CTD |
PMID:30545405 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acat2l1 |
acetyl-CoA acetyltransferase 2-like 1 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACAT2L1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 1:47,803,822...47,829,012
Ensembl chr 1:47,803,813...47,829,151
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACE2 protein |
CTD |
PMID:30545405 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions affects activity |
EXP |
zingerone affects the reaction [Vancomycin affects the activity of ACHE protein] |
CTD |
PMID:31454121 |
|
NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acot3 |
acyl-CoA thioesterase 3 |
increases expression |
ISO |
Vancomycin results in increased expression of ACOT3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
increases expression |
ISO |
Vancomycin results in increased expression of ACOT4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acot9 |
acyl-CoA thioesterase 9 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ACOT9 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:40,073,197...40,123,573
Ensembl chr X:40,064,810...40,123,559
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of ACOX2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
increases expression |
ISO |
Vancomycin results in increased expression of ACSL1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ACSL4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acsm1 |
acyl-CoA synthetase medium-chain family member 1 |
increases expression |
ISO |
Vancomycin results in increased expression of ACSM1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:173,985,715...174,020,565
Ensembl chr 1:173,984,672...174,025,495
|
|
G |
Acsm2 |
acyl-CoA synthetase medium-chain family member 2 |
increases expression |
ISO |
Vancomycin results in increased expression of ACSM2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
increases expression |
ISO |
Vancomycin results in increased expression of ACSM3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
|
|
G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
increases expression |
ISO |
Vancomycin results in increased expression of ACSS1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
increases expression |
ISO |
Vancomycin results in increased expression of ACSS2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression |
ISO |
Vancomycin results in decreased expression of ACTA2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actb |
actin, beta |
increases expression |
ISO |
Vancomycin results in increased expression of ACTB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actn1 |
actinin, alpha 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ACTN1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Acy1 |
aminoacylase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of ACY1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Acy3 |
aminoacylase 3 |
increases expression |
ISO |
Vancomycin results in increased expression of ACY3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:201,279,751...201,285,803
Ensembl chr 1:201,279,851...201,283,175
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ADAMTS1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adgre5 |
adhesion G protein-coupled receptor E5 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ADGRE5 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:24,397,972...24,418,648
Ensembl chr19:24,398,689...24,418,638
|
|
G |
Adhfe1 |
alcohol dehydrogenase, iron containing, 1 |
increases expression |
ISO |
Vancomycin results in increased expression of ADHFE1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
ISO |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of ADIPOQ mRNA |
CTD |
PMID:34979169 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adk |
adenosine kinase |
increases expression |
ISO |
Vancomycin results in increased expression of ADK mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
|
|
G |
Adra2b |
adrenoceptor alpha 2B |
increases expression |
ISO |
Vancomycin results in increased expression of ADRA2B mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355
|
|
G |
Aebp1 |
AE binding protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of AEBP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877
|
|
G |
Afm |
afamin |
increases expression |
ISO |
Vancomycin results in increased expression of AFM mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:17,531,026...17,563,868
Ensembl chr14:17,531,024...17,563,870
|
|
G |
Agmat |
agmatinase |
increases expression |
ISO |
Vancomycin results in increased expression of AGMAT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:154,043,665...154,074,278
Ensembl chr 5:154,060,151...154,074,276
|
|
G |
Agrn |
agrin |
decreases expression |
ISO |
Vancomycin results in decreased expression of AGRN mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:166,749,306...166,782,212
Ensembl chr 5:166,749,310...166,786,003
|
|
G |
Agxt2 |
alanine-glyoxylate aminotransferase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of AGXT2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:59,336,252...59,377,664
Ensembl chr 2:59,336,283...59,377,926
|
|
G |
Ahcy |
adenosylhomocysteinase |
increases expression |
ISO |
Vancomycin results in increased expression of AHCY mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Ahnak |
AHNAK nucleoprotein |
decreases expression |
ISO |
Vancomycin results in decreased expression of AHNAK mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:205,882,223...205,970,934
Ensembl chr 1:205,882,273...205,970,926
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of AHSG protein |
CTD |
PMID:30545405 |
|
NCBI chr11:78,117,903...78,145,956
Ensembl chr11:78,117,918...78,145,999
|
|
G |
Ak4 |
adenylate kinase 4 |
increases expression |
ISO |
Vancomycin results in increased expression of AK4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
decreases expression |
ISO |
Vancomycin results in decreased expression of AKAP12 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
increases expression |
ISO |
Vancomycin results in increased expression of AKR1D1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
increases expression |
ISO |
Vancomycin results in increased expression of AKR7A5 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Alb |
albumin |
increases expression |
ISO |
Vancomycin results in increased expression of ALB1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh16a1 |
aldehyde dehydrogenase 16 family, member A1 |
increases expression |
ISO |
Vancomycin results in increased expression of ALDH16A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:95,626,727...95,639,808
Ensembl chr 1:95,613,558...95,640,131
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
decreases expression |
EXP |
Vancomycin results in decreased expression of ALDH1A1 mRNA |
CTD |
PMID:18289764 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ALDH1A2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
increases expression |
ISO |
Vancomycin results in increased expression of ALDH2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
increases expression |
ISO |
Vancomycin results in increased expression of ALDH4A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
increases expression |
ISO |
Vancomycin results in increased expression of ALDH5A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
increases expression |
ISO |
Vancomycin results in increased expression of ALDH6A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
increases expression |
ISO |
Vancomycin results in increased expression of ALDH7A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
|
|
G |
Aldh8a1 |
aldehyde dehydrogenase 8 family, member A1 |
increases expression |
ISO |
Vancomycin results in increased expression of ALDH8A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:16,183,940...16,203,385
Ensembl chr 1:16,183,940...16,203,385
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
increases expression |
ISO |
Vancomycin results in increased expression of ALDH9A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOA protein |
CTD |
PMID:30545405 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOB protein |
CTD |
PMID:30545405 |
|
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
increases expression |
ISO |
Vancomycin results in increased expression of ALDOC mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
Vancomycin results in increased expression of ALPL mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Amacr |
alpha-methylacyl-CoA racemase |
increases expression |
ISO |
Vancomycin results in increased expression of AMACR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255
|
|
G |
Ampd3 |
adenosine monophosphate deaminase 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of AMPD3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
|
|
G |
Angpt1 |
angiopoietin 1 |
increases expression |
ISO |
Vancomycin results in increased expression of ANGPT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Angptl3 |
angiopoietin-like 3 |
increases expression |
ISO |
Vancomycin results in increased expression of ANGPTL3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
|
|
G |
Angptl4 |
angiopoietin-like 4 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ankrd13c |
ankyrin repeat domain 13C |
increases expression |
ISO |
Vancomycin results in increased expression of ANKRD13C mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:247,023,040...247,070,433
Ensembl chr 2:247,022,286...247,070,433
|
|
G |
Ano6 |
anoctamin 6 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ANO6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:126,933,629...127,113,589
Ensembl chr 7:126,933,936...127,113,589
|
|
G |
Anxa1 |
annexin A1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ANXA1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa2 |
annexin A2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ANXA2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa3 |
annexin A3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ANXA3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Anxa5 |
annexin A5 |
decreases expression increases expression |
ISO EXP |
Vancomycin results in decreased expression of ANXA5 mRNA Vancomycin results in increased expression of ANXA5 mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Aoah |
acyloxyacyl hydrolase |
increases expression |
ISO |
Vancomycin results in increased expression of AOAH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:43,808,110...44,049,458
Ensembl chr17:43,809,638...44,049,148
|
|
G |
Aoc1 |
amine oxidase, copper containing 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of AOC1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
|
|
G |
Apeh |
acylaminoacyl-peptide hydrolase |
increases expression |
ISO |
Vancomycin results in increased expression of APEH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:108,773,791...108,782,903
Ensembl chr 8:108,773,794...108,782,933
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of APEX1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apom |
apolipoprotein M |
increases expression |
ISO |
Vancomycin results in increased expression of APOM mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:3,690,950...3,693,550
Ensembl chr20:3,688,413...3,693,550
|
|
G |
Aqp11 |
aquaporin 11 |
increases expression |
ISO |
Vancomycin results in increased expression of AQP11 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:152,046,515...152,056,675
Ensembl chr 1:152,046,517...152,056,725
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
increases expression |
ISO |
Vancomycin results in increased expression of AQP3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Ar |
androgen receptor |
increases expression |
ISO |
Vancomycin results in increased expression of AR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arg2 |
arginase 2 |
decreases expression multiple interactions |
ISO EXP |
Vancomycin results in decreased expression of ARG2 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ARG2 protein |
CTD |
PMID:18930951 PMID:30545405 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgap18 |
Rho GTPase activating protein 18 |
increases expression |
ISO |
Vancomycin results in increased expression of ARHGAP18 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
decreases expression |
ISO |
Vancomycin results in decreased expression of ARHGDIB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Armcx3 |
armadillo repeat containing, X-linked 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ARMCX3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:97,937,115...97,942,098
Ensembl chr X:97,936,999...97,942,098
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
decreases expression |
ISO |
Vancomycin results in decreased expression of ARPC1B mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
|
|
G |
Arpc3 |
actin related protein 2/3 complex, subunit 3 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ARPC3 protein |
CTD |
PMID:30545405 |
|
NCBI chr12:34,172,780...34,186,651
Ensembl chr12:34,172,780...34,186,651
|
|
G |
Arrb2 |
arrestin, beta 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ARRB2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ASAH1 protein |
CTD |
PMID:30545405 |
|
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
|
|
G |
Asl |
argininosuccinate lyase |
increases expression |
ISO |
Vancomycin results in increased expression of ASL mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Aspa |
aspartoacylase |
increases expression |
ISO |
Vancomycin results in increased expression of ASPA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of ASS1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP1A1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp2a3 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP2A3 protein |
CTD |
PMID:30545405 |
|
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
|
|
G |
Atp5mf |
ATP synthase membrane subunit f |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5J2 protein |
CTD |
PMID:30545405 |
|
NCBI chr12:9,421,665...9,428,236
Ensembl chr12:9,421,579...9,428,236
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5H protein |
CTD |
PMID:30545405 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5J protein |
CTD |
PMID:30545405 |
|
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
|
|
G |
Atp6v1b1 |
ATPase H+ transporting V1 subunit B1 |
increases expression |
ISO |
Vancomycin results in increased expression of ATP6V1B1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:116,223,799...116,242,475
Ensembl chr 4:116,223,799...116,242,475
|
|
G |
Atp6v1c2 |
ATPase H+ transporting V1 subunit C2 |
increases expression |
ISO |
Vancomycin results in increased expression of ATP6V1C2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028
|
|
G |
Auh |
AU RNA binding methylglutaconyl-CoA hydratase |
increases expression |
ISO |
Vancomycin results in increased expression of AUH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:12,329,522...12,424,896
Ensembl chr17:12,329,524...12,424,896
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
increases expression |
ISO |
Vancomycin results in increased expression of AVPR1A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
ISO |
Vancomycin results in decreased expression of AXL mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:81,265,656...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
B2m |
beta-2 microglobulin |
decreases expression |
ISO |
Vancomycin results in decreased expression of B2M mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
B3galnt1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
increases expression |
ISO |
Vancomycin results in increased expression of B3GALNT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:153,847,297...153,877,371
Ensembl chr 2:153,846,474...153,877,332
|
|
G |
B3galt5 |
Beta-1,3-galactosyltransferase 5 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of B3GALT5 protein |
CTD |
PMID:30545405 |
|
NCBI chr11:35,584,273...35,630,922
Ensembl chr11:35,585,220...35,630,917
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
multiple interactions |
ISO |
[Vancomycin co-treated with Imipenem] results in decreased expression of BAAT mRNA |
CTD |
PMID:24657338 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bag2 |
BAG cochaperone 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of BAG2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:35,970,033...35,980,677
Ensembl chr 9:35,970,033...35,980,721
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP |
Vancomycin results in increased expression of BAX protein JBP 485 inhibits the reaction [Vancomycin results in increased expression of BAX protein] |
CTD |
PMID:29964132 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of BBOX1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bcam |
basal cell adhesion molecule (Lutheran blood group) |
decreases expression |
ISO |
Vancomycin results in decreased expression of BCAM mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403
|
|
G |
Bcar3 |
BCAR3 adaptor protein, NSP family member |
increases expression |
ISO |
Vancomycin results in increased expression of BCAR3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
|
|
G |
Bche |
butyrylcholinesterase |
affects activity multiple interactions |
EXP |
Vancomycin affects the activity of BCHE protein zingerone affects the reaction [Vancomycin affects the activity of BCHE protein] |
CTD |
PMID:31454121 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bckdha |
branched chain keto acid dehydrogenase E1 subunit alpha |
increases expression |
ISO |
Vancomycin results in increased expression of BCKDHA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:81,138,946...81,167,765
Ensembl chr 1:81,138,947...81,167,862
|
|
G |
Bckdhb |
branched chain keto acid dehydrogenase E1 subunit beta |
increases expression |
ISO |
Vancomycin results in increased expression of BCKDHB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:84,845,264...85,027,812
Ensembl chr 8:84,845,264...85,027,812
|
|
G |
Bcl10 |
BCL10, immune signaling adaptor |
decreases expression |
ISO |
Vancomycin results in decreased expression of BCL10 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:234,840,880...234,850,520
Ensembl chr 2:234,840,858...234,850,523
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP |
JBP 485 inhibits the reaction [Vancomycin results in decreased expression of BCL2 protein] |
CTD |
PMID:29964132 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of BDH1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of BDH2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Bgn |
biglycan |
decreases expression |
ISO |
Vancomycin results in decreased expression of BGN mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
increases expression |
ISO |
Vancomycin results in increased expression of BHMT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bhmt2 |
betaine-homocysteine S-methyltransferase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of BHMT2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475
|
|
G |
Bicc1 |
BicC family RNA binding protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of BICC1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:17,449,644...17,686,775
Ensembl chr20:17,449,560...17,686,776
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of BIRC3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Blnk |
B-cell linker |
decreases expression |
ISO |
Vancomycin results in decreased expression of BLNK mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
|
|
G |
Bmp1 |
bone morphogenetic protein 1 |
increases expression |
EXP |
Vancomycin results in increased expression of BMP1 mRNA |
CTD |
PMID:18289764 |
|
NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776
|
|
G |
Bnip2 |
BCL2 interacting protein 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of BNIP2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:70,640,436...70,661,782
Ensembl chr 8:70,640,445...70,675,590
|
|
G |
Bphl |
biphenyl hydrolase like |
increases expression |
ISO |
Vancomycin results in increased expression of BPHL mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288
|
|
G |
Bpnt1 |
3'(2'), 5'-bisphosphate nucleotidase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of BPNT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:96,865,634...96,893,506
Ensembl chr13:96,868,580...96,893,503
|
|
G |
Bsnd |
barttin CLCNK type accessory subunit beta |
increases expression |
ISO |
Vancomycin results in increased expression of BSND mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:121,251,774...121,260,571
Ensembl chr 5:121,251,774...121,260,571
|
|
G |
Bspry |
B-box and SPRY domain containing |
decreases expression |
ISO |
Vancomycin results in decreased expression of BSPRY mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:75,927,397...75,949,585
Ensembl chr 5:75,927,405...75,949,583
|
|
G |
Bst1 |
bone marrow stromal cell antigen 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of BST1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of BST2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:18,217,404...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
Vancomycin results in increased expression of BTG2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
C1qa |
complement C1q A chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of C1QA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qb |
complement C1q B chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of C1QB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C1ql3 |
complement C1q like 3 |
increases expression |
ISO |
Vancomycin results in increased expression of C1QL3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:76,121,832...76,128,327
Ensembl chr17:76,119,447...76,128,530
|
|
G |
C1qtnf12 |
C1q and TNF related 12 |
increases expression |
ISO |
Vancomycin results in increased expression of C1QTNF12 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:166,551,628...166,556,003
Ensembl chr 5:166,551,628...166,556,003
|
|
G |
C1qtnf3 |
C1q and TNF related 3 |
increases expression |
ISO |
Vancomycin results in increased expression of C1QTNF3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433
|
|
G |
C1r |
complement C1r |
decreases expression |
ISO |
Vancomycin results in decreased expression of C1R mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
|
|
G |
C1s |
complement C1s |
decreases expression |
ISO |
Vancomycin results in decreased expression of C1S mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
|
|
G |
C2cd2l |
C2CD2-like |
increases expression |
ISO |
Vancomycin results in increased expression of C2CD2L mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:44,648,074...44,658,856
Ensembl chr 8:44,648,079...44,658,340
|
|
G |
C3 |
complement C3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of C3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C4b |
complement C4B (Chido blood group) |
increases expression decreases expression |
ISO |
Vancomycin results in increased expression of C4B mRNA Vancomycin results in decreased expression of C4B mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
|
|
G |
C8a |
complement C8 alpha chain |
increases expression |
ISO |
Vancomycin results in increased expression of C8A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:119,583,168...119,637,675
Ensembl chr 5:119,583,174...119,637,754
|
|
G |
Calb1 |
calbindin 1 |
increases expression decreases expression |
ISO EXP |
Vancomycin results in increased expression of CALB1 mRNA Vancomycin results in decreased expression of CALB1 mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
|
|
G |
Cald1 |
caldesmon 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CALD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:63,265,781...63,446,936
Ensembl chr 4:63,265,942...63,446,932
|
|
G |
Capg |
capping actin protein, gelsolin like |
decreases expression |
ISO |
Vancomycin results in decreased expression of CAPG mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Capn2 |
calpain 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CAPN2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Car12 |
carbonic anhydrase 12 |
increases expression |
ISO |
Vancomycin results in increased expression of CAR12 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Car14 |
carbonic anhydrase 14 |
increases expression |
ISO |
Vancomycin results in increased expression of CAR14 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:183,442,263...183,449,207
Ensembl chr 2:183,441,667...183,449,693
|
|
G |
Car5a |
carbonic anhydrase 5A |
increases expression |
ISO |
Vancomycin results in increased expression of CAR5A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions |
EXP |
Vancomycin results in increased cleavage of CASP3 protein JBP 485 inhibits the reaction [Vancomycin results in increased cleavage of CASP3 protein] |
CTD |
PMID:29964132 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casr |
calcium-sensing receptor |
increases expression |
ISO |
Vancomycin results in increased expression of CASR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811
|
|
G |
Cat |
catalase |
decreases expression increases expression |
ISO EXP |
Vancomycin results in decreased expression of CAT protein Vancomycin results in increased expression of CAT mRNA Vancomycin results in decreased expression of CAT mRNA |
CTD |
PMID:18289764 PMID:18930951 PMID:19442074 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cavin2 |
caveolae associated protein 2 |
increases expression |
ISO |
Vancomycin results in increased expression of CAVIN2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
|
|
G |
Cavin3 |
caveolae associated protein 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CAVIN3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
|
|
G |
Cbfb |
core-binding factor subunit beta |
decreases expression |
ISO |
Vancomycin results in decreased expression of CBFB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
|
|
G |
Cbr1 |
carbonyl reductase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of CBR1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:32,860,618...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cbr1l1 |
carbonyl reductase 1 like 1 |
increases expression |
ISO |
Vancomycin results in increased expression of CBR1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:32,876,563...32,884,234
|
|
G |
Cbr2 |
carbonyl reductase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of CBR2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:106,008,535...106,012,838
Ensembl chr10:105,991,589...106,013,001
|
|
G |
Cbs |
cystathionine beta synthase |
increases expression |
ISO |
Vancomycin results in increased expression of CBS mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Ccn1 |
cellular communication network factor 1 |
decreases expression |
EXP |
Vancomycin results in decreased expression of CCN1 mRNA |
CTD |
PMID:18289764 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn4 |
cellular communication network factor 4 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CCN4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
|
|
G |
Ccng1 |
cyclin G1 |
decreases expression |
EXP |
Vancomycin results in decreased expression of CCNG1 mRNA |
CTD |
PMID:18289764 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccs |
copper chaperone for superoxide dismutase |
increases expression |
ISO |
Vancomycin results in increased expression of CCS mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915
|
|
G |
Ccser2 |
coiled-coil serine-rich protein 2 |
increases expression |
ISO |
Vancomycin results in increased expression of CCSER2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:12,613,103...12,725,764
Ensembl chr16:12,613,103...12,725,738
|
|
G |
Cd14 |
CD14 molecule |
decreases expression |
ISO |
Vancomycin results in decreased expression of CD14 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd151 |
CD151 molecule (Raph blood group) |
decreases expression |
ISO |
Vancomycin results in decreased expression of CD151 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:196,564,744...196,568,753
Ensembl chr 1:196,565,181...196,568,753
|
|
G |
Cd24 |
CD24 molecule |
decreases expression increases expression |
ISO EXP |
Vancomycin results in decreased expression of CD24A mRNA Vancomycin results in increased expression of CD24 mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
increases expression |
EXP |
Vancomycin results in increased expression of CD44 mRNA |
CTD |
PMID:18289764 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd47 |
Cd47 molecule |
decreases expression |
ISO |
Vancomycin results in decreased expression of CD47 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
|
|
G |
Cd52 |
CD52 molecule |
decreases expression |
ISO |
Vancomycin results in decreased expression of CD52 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
|
|
G |
Cd74 |
CD74 molecule |
decreases expression |
ISO |
Vancomycin results in decreased expression of CD74 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd9 |
CD9 molecule |
decreases expression |
ISO |
Vancomycin results in decreased expression of CD9 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cdh11 |
cadherin 11 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CDH11 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CDK6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkl1 |
cyclin dependent kinase like 1 |
increases expression |
ISO |
Vancomycin results in increased expression of CDKL1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:88,224,154...88,273,434
Ensembl chr 6:88,224,143...88,270,276
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression |
ISO |
Vancomycin results in decreased expression of CDKN1A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2d |
cyclin dependent kinase inhibitor 2D |
decreases expression |
ISO |
Vancomycin results in decreased expression of CDKN2D mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CDT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
increases expression |
ISO |
Vancomycin results in increased expression of CEACAM1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Cela1 |
chymotrypsin like elastase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of CELA1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:131,773,161...131,786,300
Ensembl chr 7:131,742,002...131,786,285
|
|
G |
Ces3a |
carboxylesterase 3a |
increases expression |
ISO |
Vancomycin results in increased expression of CES3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cfh |
complement factor H |
decreases expression |
ISO |
Vancomycin results in decreased expression of CFH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Cfi |
complement factor I |
decreases expression |
ISO |
Vancomycin results in decreased expression of CFI mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
|
|
G |
Cgn |
cingulin |
decreases expression |
ISO |
Vancomycin results in decreased expression of CGN mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:182,308,389...182,335,747
Ensembl chr 2:182,308,714...182,334,645
|
|
G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
increases expression |
ISO |
Vancomycin results in increased expression of CGREF1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852
|
|
G |
Chpt1 |
choline phosphotransferase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of CHPT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
increases expression |
ISO |
Vancomycin results in increased expression of CHRNA4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Cklf |
chemokine-like factor |
decreases expression |
ISO |
Vancomycin results in decreased expression of CKLF mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:698,097...706,570
Ensembl chr19:698,033...706,570
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
decreases expression |
ISO |
Vancomycin results in decreased expression of CKS1B mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
|
|
G |
Clca1 |
chloride channel accessory 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CLCA1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
|
|
G |
Clca4 |
chloride channel accessory 4 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein |
CTD |
PMID:30545405 |
|
NCBI chr 2:233,883,625...233,904,993
Ensembl chr 2:233,883,851...233,903,089
|
|
G |
Clcnkb |
chloride voltage-gated channel Kb |
increases expression |
ISO |
Vancomycin results in increased expression of CLCNKB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:153,710,086...153,733,162
Ensembl chr 5:153,710,094...153,732,153
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CLDN1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn3 |
claudin 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CLDN3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Cldn5 |
claudin 5 |
multiple interactions |
ISO |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] |
CTD |
PMID:35390362 |
|
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
|
|
G |
Cldn7 |
claudin 7 |
decreases expression multiple interactions |
ISO EXP |
Vancomycin results in decreased expression of CLDN7 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLDN7 protein |
CTD |
PMID:18930951 PMID:30545405 |
|
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
|
|
G |
Clic1 |
chloride intracellular channel 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CLIC1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
|
|
G |
Clu |
clusterin |
increases expression decreases expression |
EXP ISO |
Vancomycin results in increased expression of CLU mRNA Vancomycin results in decreased expression of CLU mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cmbl |
carboxymethylenebutenolidase homolog |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CMBL protein |
CTD |
PMID:30545405 |
|
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
|
|
G |
Cmtm3 |
CKLF-like MARVEL transmembrane domain containing 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CMTM3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:622,563...630,721
Ensembl chr19:604,458...629,790
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of CNDP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
|
|
G |
Cndp2 |
carnosine dipeptidase 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein |
CTD |
PMID:30545405 |
|
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
|
|
G |
Cnn2 |
calponin 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CNN2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:9,712,505...9,719,711
Ensembl chr 7:9,712,516...9,719,656
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
decreases expression |
ISO |
Vancomycin results in decreased expression of CNP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Coasy |
Coenzyme A synthase |
increases expression |
ISO |
Vancomycin results in increased expression of COASY mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:86,014,566...86,018,849
Ensembl chr10:86,014,597...86,018,841
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of COL18A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of COL1A2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of COL3A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of COL4A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of COL4A2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of COL5A2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:47,448,736...47,598,396
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of COL6A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of COL6A3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
|
|
G |
Col8a1 |
collagen type VIII alpha 1 chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of COL8A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
|
|
G |
Coq8a |
coenzyme Q8A |
increases expression |
ISO |
Vancomycin results in increased expression of COQ8A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431
|
|
G |
Coro1c |
coronin 1C |
decreases expression |
ISO |
Vancomycin results in decreased expression of CORO1C mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:42,712,960...42,785,179
Ensembl chr12:42,712,991...42,785,179
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX5A protein |
CTD |
PMID:30545405 |
|
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
|
|
G |
Cox6b1 |
cytochrome c oxidase subunit 6B1 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX6B1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 1:85,875,080...85,884,081
Ensembl chr 1:85,875,109...85,884,001
|
|
G |
Cox7a1 |
cytochrome c oxidase subunit 7A1 |
increases expression |
ISO |
Vancomycin results in increased expression of COX7A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:85,422,162...85,447,530
Ensembl chr 1:85,441,871...85,445,151
|
|
G |
Cox7a2 |
cytochrome c oxidase subunit 7A2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX7A2 protein |
CTD |
PMID:30545405 |
|
NCBI chr 8:80,716,824...80,720,922
Ensembl chr14:51,301,168...51,301,633
|
|
G |
Cp |
ceruloplasmin |
decreases expression increases expression |
ISO EXP |
Vancomycin results in decreased expression of CP mRNA Vancomycin results in increased expression of CP mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpe |
carboxypeptidase E |
decreases expression |
ISO |
Vancomycin results in decreased expression of CPE mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
|
|
G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
increases expression |
ISO |
Vancomycin results in increased expression of CPEB3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
|
|
G |
Crem |
cAMP responsive element modulator |
decreases expression |
ISO |
Vancomycin results in decreased expression of CREM mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Crip1 |
cysteine rich protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CRIP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:132,226,746...132,234,620
Ensembl chr 6:132,226,746...132,234,620
|
|
G |
Crp |
C-reactive protein |
decreases expression |
ISO |
Vancomycin results in decreased expression of CRP protein |
CTD |
PMID:12680319 |
|
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cryl1 |
crystallin, lambda 1 |
increases expression |
ISO |
Vancomycin results in increased expression of CRYL1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
|
|
G |
Csad |
cysteine sulfinic acid decarboxylase |
increases expression |
ISO |
Vancomycin results in increased expression of CSAD mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of CSF2 protein |
CTD |
PMID:31442584 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf2ra |
colony stimulating factor 2 receptor subunit alpha |
decreases expression |
ISO |
Vancomycin results in decreased expression of CSF2RA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:98,089...103,261
Ensembl chr14:89,172...103,128
|
|
G |
Csnk1e |
casein kinase 1, epsilon |
decreases expression |
ISO |
Vancomycin results in decreased expression of CSNK1E mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:110,983,322...111,006,926
Ensembl chr 7:110,983,318...111,006,794
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CSRP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Cstb |
cystatin B |
decreases expression |
ISO |
Vancomycin results in decreased expression of CSTB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:10,245,462...10,247,505
Ensembl chr20:10,245,462...10,247,526
|
|
G |
Cth |
cystathionine gamma-lyase |
increases expression |
ISO |
Vancomycin results in increased expression of CTH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctps1 |
CTP synthase 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CTPS mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
|
|
G |
Ctsa |
cathepsin A |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CTSA protein |
CTD |
PMID:30545405 |
|
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
|
|
G |
Ctsc |
cathepsin C |
decreases expression |
ISO |
Vancomycin results in decreased expression of CTSC mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
|
|
G |
Ctsd |
cathepsin D |
decreases expression |
ISO |
Vancomycin results in decreased expression of CTSD mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctsl |
cathepsin L |
decreases expression |
ISO |
Vancomycin results in decreased expression of CTSL mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Ctss |
cathepsin S |
decreases expression increases expression |
ISO EXP |
Vancomycin results in decreased expression of CTSS mRNA Vancomycin results in increased expression of CTSS mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr 2:183,089,192...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Cttnbp2nl |
CTTNBP2 N-terminal like |
decreases expression |
ISO |
Vancomycin results in decreased expression of CTTNBP2NL mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:192,507,963...192,554,548
Ensembl chr 2:192,507,963...192,541,101
|
|
G |
Cubn |
cubilin |
increases expression |
ISO |
Vancomycin results in increased expression of CUBN mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:76,385,046...76,593,133
Ensembl chr17:76,385,060...76,593,231
|
|
G |
Cul3 |
cullin 3 |
increases expression |
ISO |
Vancomycin results in increased expression of CUL3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:81,592,641...81,670,428
Ensembl chr 9:81,592,641...81,670,462
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CX3CL1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
decreases expression |
ISO |
Vancomycin results in decreased expression of CXADR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:16,982,752...17,030,078
Ensembl chr11:16,982,860...17,030,046
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression |
ISO |
Vancomycin results in increased expression of CXCL12 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl16 |
C-X-C motif chemokine ligand 16 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CXCL16 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:55,166,721...55,171,316
Ensembl chr10:55,166,723...55,171,592
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
Vancomycin results in increased expression of CXCL1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
multiple interactions |
ISO |
[Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of CXCL9 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of CXCL9 mRNA]] |
CTD |
PMID:32068018 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cyb561 |
cytochrome b-561 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CYB561 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:90,878,052...90,888,734
Ensembl chr10:90,878,054...90,884,787
|
|
G |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
increases expression |
ISO |
Vancomycin results in increased expression of CYFIP2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA |
CTD |
PMID:30545405 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CYP1B1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
increases expression |
ISO |
Vancomycin results in increased expression of CYP27A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of CYP27B1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2C11 mRNA |
CTD |
PMID:30545405 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2d2 |
cytochrome P450, family 2, subfamily d, polypeptide 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2D2 mRNA |
CTD |
PMID:30545405 |
|
NCBI chr 7:113,935,138...113,939,209
Ensembl chr 7:113,935,138...113,939,209
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
increases expression |
ISO |
Vancomycin results in increased expression of CYP2D22 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:30545405 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP3A2 mRNA |
CTD |
PMID:30545405 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
increases expression |
ISO |
Vancomycin results in increased expression of CYP51 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions |
ISO |
[Vancomycin co-treated with Imipenem] results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
multiple interactions |
ISO |
[Vancomycin co-treated with Imipenem] results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dap |
death-associated protein |
decreases expression |
ISO |
Vancomycin results in decreased expression of DAP mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
|
|
G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
increases expression |
ISO |
Vancomycin results in increased expression of DBT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
increases expression |
ISO |
Vancomycin results in increased expression of DCXR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:106,006,404...106,008,294
|
|
G |
Ddah2 |
dimethylarginine dimethylaminohydrolase 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of DDAH2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
|
|
G |
Ddc |
dopa decarboxylase |
increases expression |
ISO |
Vancomycin results in increased expression of DDC mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
ISO |
Vancomycin results in increased expression of DDIT4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddt |
D-dopachrome tautomerase |
increases expression |
ISO |
Vancomycin results in increased expression of DDT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
|
|
G |
Decr2 |
2,4-dienoyl-CoA reductase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of DECR2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of DGAT2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
increases expression |
ISO |
Vancomycin results in increased expression of DHRS3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dhtkd1 |
dehydrogenase E1 and transketolase domain containing 1 |
increases expression |
ISO |
Vancomycin results in increased expression of DHTKD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:72,355,201...72,406,725
Ensembl chr17:72,355,201...72,406,723
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of DIO1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Dmgdh |
dimethylglycine dehydrogenase |
increases expression |
ISO |
Vancomycin results in increased expression of DMGDH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
|
|
G |
Dmtn |
dematin actin binding protein |
increases expression |
ISO |
Vancomycin results in increased expression of DMTN mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:45,677,974...45,705,601
Ensembl chr15:45,677,977...45,705,601
|
|
G |
Dnajc12 |
DnaJ heat shock protein family (Hsp40) member C12 |
increases expression |
ISO |
Vancomycin results in increased expression of DNAJC12 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:25,246,744...25,267,508
Ensembl chr20:25,223,144...25,267,521
|
|
G |
Dnajc28 |
DnaJ heat shock protein family (Hsp40) member C28 |
increases expression |
ISO |
Vancomycin results in increased expression of DNAJC28 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:30,855,566...30,858,386
Ensembl chr11:30,853,526...30,858,441
|
|
G |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
increases expression |
ISO |
Vancomycin results in increased expression of DNAJC6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:116,120,069...116,283,448
Ensembl chr 5:116,119,676...116,283,448
|
|
G |
Dnase1 |
deoxyribonuclease 1 |
increases expression |
ISO |
Vancomycin results in increased expression of DNASE1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:11,498,930...11,505,151
Ensembl chr10:11,498,931...11,501,869
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of DNMT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dock9 |
dedicator of cytokinesis 9 |
increases expression |
ISO |
Vancomycin results in increased expression of DOCK9 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:98,611,518...98,883,306
Ensembl chr15:98,618,084...98,883,153
|
|
G |
Dpep1 |
dipeptidase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of DPEP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:51,209,831...51,237,004
Ensembl chr19:51,219,660...51,235,257
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
increases expression |
ISO |
Vancomycin results in increased expression of DPP4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:46,962,243...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
increases expression |
ISO |
Vancomycin results in increased expression of DPYD mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dpys |
dihydropyrimidinase |
increases expression |
ISO |
Vancomycin results in increased expression of DPYS mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
|
|
G |
Dtx3l |
deltex E3 ubiquitin ligase 3L |
decreases expression |
ISO |
Vancomycin results in decreased expression of DTX3L mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:64,814,926...64,824,538
Ensembl chr11:64,814,926...64,824,538
|
|
G |
Dtx4 |
deltex E3 ubiquitin ligase 4 |
decreases expression |
ISO |
Vancomycin results in decreased expression of DTX4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818
|
|
G |
Dym |
dymeclin |
increases expression |
ISO |
Vancomycin results in increased expression of DYM mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:68,605,131...68,900,905
Ensembl chr18:68,605,185...68,900,903
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of DYNLL1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:41,312,367...41,314,742
Ensembl chr12:41,312,367...41,314,741
|
|
G |
Echdc3 |
enoyl CoA hydratase domain containing 3 |
increases expression |
ISO |
Vancomycin results in increased expression of ECHDC3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EFEMP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Efemp2 |
EGF containing fibulin extracellular matrix protein 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EFEMP2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
|
|
G |
Efhd1 |
EF-hand domain family, member D1 |
increases expression |
ISO |
Vancomycin results in increased expression of EFHD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:87,938,259...87,984,917
Ensembl chr 9:87,938,284...87,984,917
|
|
G |
Efhd2 |
EF-hand domain family, member D2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EFHD2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:154,160,945...154,176,980
Ensembl chr 5:154,160,946...154,176,980
|
|
G |
Egf |
epidermal growth factor |
decreases expression increases expression |
EXP ISO |
Vancomycin results in decreased expression of EGF mRNA Vancomycin results in increased expression of EGF mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfl6 |
EGF-like-domain, multiple 6 |
increases expression |
ISO |
Vancomycin results in increased expression of EGFL6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:27,884,087...27,942,044
Ensembl chr X:27,884,125...27,942,044
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
ISO |
Vancomycin results in increased expression of EGR1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Ehd4 |
EH-domain containing 4 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EHD4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:107,058,191...107,121,985
Ensembl chr 3:107,058,958...107,122,002
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
increases expression |
ISO |
Vancomycin results in increased expression of EHHADH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Eif1a |
eukaryotic translation initiation factor 1A |
decreases expression |
ISO |
Vancomycin results in decreased expression of EIF1A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:39,325,695...39,338,043
Ensembl chr18:39,325,202...39,338,696
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EIF2AK2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
|
|
G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EIF4A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:54,384,345...54,389,853
Ensembl chr10:54,384,347...54,389,858
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EIF4EBP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Eif6 |
eukaryotic translation initiation factor 6 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EIF6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
|
|
G |
Elf3 |
E74 like ETS transcription factor 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ELF3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
|
|
G |
Ell3 |
elongation factor for RNA polymerase II 3 |
increases expression |
ISO |
Vancomycin results in increased expression of ELL3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:108,413,035...108,417,181
Ensembl chr 3:108,410,448...108,417,132
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
increases expression |
ISO |
Vancomycin results in increased expression of ELOVL6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EMILIN1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:25,455,974...25,463,736
Ensembl chr 6:25,445,298...25,463,698
|
|
G |
Emp1 |
epithelial membrane protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EMP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Emp2 |
epithelial membrane protein 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EMP2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:5,360,073...5,394,734
Ensembl chr10:5,360,073...5,394,733
|
|
G |
Emp3 |
epithelial membrane protein 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EMP3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ENC1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of ENPP2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
increases expression |
ISO |
Vancomycin results in increased expression of ENTPD5 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
|
|
G |
Epcam |
epithelial cell adhesion molecule |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EPCAM protein |
CTD |
PMID:30545405 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
decreases expression |
ISO |
Vancomycin results in decreased expression of ERCC1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Erh |
ERH, mRNA splicing and mitosis factor |
decreases expression |
ISO |
Vancomycin results in decreased expression of ERH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:100,280,930...100,291,449
Ensembl chr 6:100,280,930...100,291,210
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
increases expression |
ISO |
Vancomycin results in increased expression of ERRFI1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
|
|
G |
Esrrb |
estrogen-related receptor beta |
increases expression |
ISO |
Vancomycin results in increased expression of ESRRB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:106,007,662...106,163,136
Ensembl chr 6:106,008,095...106,160,791
|
|
G |
Esyt1 |
extended synaptotagmin 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ESYT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:928,848...946,199
Ensembl chr 7:928,848...946,199
|
|
G |
Etfa |
electron transfer flavoprotein subunit alpha |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ETFA protein |
CTD |
PMID:30545405 |
|
NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969
|
|
G |
Etnk1 |
ethanolamine kinase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of ETNK1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
decreases expression |
ISO |
Vancomycin results in decreased expression of ETS2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Evc |
EvC ciliary complex subunit 1 |
increases expression |
ISO |
Vancomycin results in increased expression of EVC mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:73,456,181...73,498,955
Ensembl chr14:73,456,222...73,498,099
|
|
G |
Evl |
Enah/Vasp-like |
decreases expression |
ISO |
Vancomycin results in decreased expression of EVL mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:127,473,119...127,594,342
Ensembl chr 6:127,474,543...127,594,344
|
|
G |
Exoc6 |
exocyst complex component 6 |
decreases expression |
ISO |
Vancomycin results in decreased expression of EXOC6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:235,314,612...235,457,824
Ensembl chr 1:235,300,369...235,457,015
|
|
G |
Ezr |
ezrin |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EZR protein |
CTD |
PMID:30545405 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F13b |
coagulation factor XIII B chain |
increases expression |
ISO |
Vancomycin results in increased expression of F13B mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:51,130,851...51,156,383
Ensembl chr13:51,130,920...51,156,381
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
decreases expression |
ISO |
Vancomycin results in decreased expression of F2R mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of F2RL1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
|
|
G |
F3 |
coagulation factor III, tissue factor |
decreases expression |
ISO |
Vancomycin results in decreased expression of F3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Faah |
fatty acid amide hydrolase |
increases expression |
ISO |
Vancomycin results in increased expression of FAAH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
increases expression |
ISO |
Vancomycin results in increased expression of FABP7 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
|
|
G |
Fads6 |
fatty acid desaturase 6 |
increases expression |
ISO |
Vancomycin results in increased expression of FADS6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:100,522,981...100,538,181
Ensembl chr10:100,522,981...100,538,181
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
increases expression |
ISO |
Vancomycin results in increased expression of FAH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Fahd1 |
fumarylacetoacetate hydrolase domain containing 1 |
increases expression |
ISO |
Vancomycin results in increased expression of FAHD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:13,873,539...13,874,978
Ensembl chr10:13,873,527...13,875,012
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
ISO |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased expression of FASN mRNA] |
CTD |
PMID:34979169 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of FBN1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of FBP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fbxo39 |
F-box protein 39 |
decreases expression |
ISO |
Vancomycin results in decreased expression of FBXO39 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:56,929,699...56,934,911
Ensembl chr10:56,932,297...56,934,906
|
|
G |
Fbxo7 |
F-box protein 7 |
increases expression |
ISO |
Vancomycin results in increased expression of FBXO7 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:17,809,224...17,837,549
Ensembl chr 7:17,809,231...17,837,530
|
|
G |
Fga |
fibrinogen alpha chain |
decreases expression |
ISO |
Vancomycin results in decreased expression of FGA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:168,365,364...168,381,533
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgf9 |
fibroblast growth factor 9 |
increases expression |
ISO |
Vancomycin results in increased expression of FGF9 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
increases expression |
ISO |
Vancomycin results in increased expression of FGFR3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Flna |
filamin A |
decreases expression |
ISO |
Vancomycin results in decreased expression of FLNA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Flot1 |
flotillin 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of FLOT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:2,917,864...2,927,993
Ensembl chr20:2,917,137...2,927,978
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of FMO2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
|
|
G |
Fn1 |
fibronectin 1 |
increases expression decreases expression |
EXP ISO |
Vancomycin results in increased expression of FN1 mRNA Vancomycin results in decreased expression of FN1 mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fn3k |
fructosamine 3 kinase |
increases expression |
ISO |
Vancomycin results in increased expression of FN3K mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:106,700,302...106,715,903
Ensembl chr10:106,700,670...106,715,895
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Vancomycin results in increased expression of FOS mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
decreases expression |
ISO |
Vancomycin results in decreased expression of FOSL2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:24,297,898...24,319,157
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
Foxq1 |
forkhead box Q1 |
increases expression |
ISO |
Vancomycin results in increased expression of FOXQ1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377 Ensembl chr17:32,912,744...32,915,377
|
|
G |
Frk |
fyn-related Src family tyrosine kinase |
decreases expression |
ISO |
Vancomycin results in decreased expression of FRK mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:38,265,416...38,371,038
Ensembl chr20:38,265,280...38,371,114
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of FSCN1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
|
|
G |
Fst |
follistatin |
decreases expression |
ISO |
Vancomycin results in decreased expression of FST mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
Fstl1 |
follistatin-like 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of FSTL1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:62,895,391...62,948,581
Ensembl chr11:62,779,783...62,948,677
|
|
G |
Fut9 |
fucosyltransferase 9 |
increases expression |
ISO |
Vancomycin results in increased expression of FUT9 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:39,351,815...39,565,256
Ensembl chr 5:39,351,819...39,565,130
|
|
G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
decreases expression |
ISO |
Vancomycin results in decreased expression of FXYD5 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
increases expression decreases expression |
ISO EXP |
Vancomycin results in increased expression of G6PC mRNA Vancomycin results in decreased expression of G6PC1 mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gabrb3 |
gamma-aminobutyric acid type A receptor subunit beta 3 |
increases expression |
ISO |
Vancomycin results in increased expression of GABRB3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:108,467,047...108,702,522
Ensembl chr 1:108,296,124...108,698,961
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
decreases expression |
EXP |
Vancomycin results in decreased expression of GADD45A mRNA |
CTD |
PMID:18289764 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Galm |
galactose mutarotase |
increases expression |
ISO |
Vancomycin results in increased expression of GALM mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
|
|
G |
Galnt11 |
polypeptide N-acetylgalactosaminyltransferase 11 |
increases expression |
ISO |
Vancomycin results in increased expression of GALNT11 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
increases expression |
ISO |
Vancomycin results in increased expression of GAMT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:9,448,590...9,451,778
Ensembl chr 7:9,448,628...9,451,778
|
|
G |
Gas2 |
growth arrest-specific 2 |
increases expression |
ISO |
Vancomycin results in increased expression of GAS2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
|
|
G |
Gas5 |
growth arrest specific 5 |
decreases expression |
ISO |
Vancomycin results in decreased expression of GAS5 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:73,303,611...73,306,932
|
|
G |
Gatm |
glycine amidinotransferase |
increases expression |
ISO |
Vancomycin results in increased expression of GATM mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
|
|
G |
Gbp2 |
guanylate binding protein 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of GBP2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G |
Gbp6 |
guanylate binding protein family member 6 |
decreases expression |
ISO |
Vancomycin results in decreased expression of GBP6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062
|
|
G |
Gcat |
glycine C-acetyltransferase |
increases expression |
ISO |
Vancomycin results in increased expression of GCAT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
|
|
G |
Gcdh |
glutaryl-CoA dehydrogenase |
increases expression |
ISO |
Vancomycin results in increased expression of GCDH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:23,263,215...23,269,689
Ensembl chr19:23,263,264...23,269,681
|
|
G |
Gcgr |
glucagon receptor |
increases expression |
ISO |
Vancomycin results in increased expression of GCGR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:105,808,474...105,816,641
Ensembl chr10:105,808,473...105,816,640
|
|
G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
increases expression |
ISO |
Vancomycin results in increased expression of GCHFR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
|
|
G |
Gcsh |
glycine cleavage system protein H |
increases expression |
ISO |
Vancomycin results in increased expression of GCSH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:45,036,013...45,046,770
Ensembl chr19:45,036,011...45,046,792
|
|
G |
Gda |
guanine deaminase |
decreases expression |
ISO |
Vancomycin results in decreased expression of GDA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
|
|
G |
Gfpt2 |
glutamine-fructose-6-phosphate transaminase 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein |
CTD |
PMID:30545405 |
|
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of GGT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GIPC2 protein |
CTD |
PMID:30545405 |
|
NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
increases expression |
ISO |
Vancomycin results in increased expression of GJB1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
increases expression |
ISO |
Vancomycin results in increased expression of GJB2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Gk |
glycerol kinase |
increases expression |
ISO |
Vancomycin results in increased expression of GK mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Glul |
glutamate-ammonia ligase |
increases expression |
ISO EXP |
Vancomycin results in increased expression of GLUL mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr13:65,969,064...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Glyat |
glycine-N-acyltransferase |
increases expression |
ISO |
Vancomycin results in increased expression of GLYAT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:209,704,178...209,724,949
Ensembl chr 1:209,704,268...209,724,942
|
|
G |
Gm2a |
ganglioside GM2 activator |
increases expression |
ISO |
Vancomycin results in increased expression of GM2A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757
|
|
G |
Gmds |
GDP-mannose 4, 6-dehydratase |
decreases expression |
ISO |
Vancomycin results in decreased expression of GMDS mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:32,095,315...32,621,975
Ensembl chr17:32,095,386...32,621,961
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of GNAI2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnb1 |
G protein subunit beta 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of GNB1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
|
|
G |
Gng10 |
G protein subunit gamma 10 |
decreases expression |
ISO |
Vancomycin results in decreased expression of GNG10 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:73,856,124...73,863,017
Ensembl chr 5:73,856,164...73,863,012
|
|
G |
Gng12 |
G protein subunit gamma 12 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GNG12 protein |
CTD |
PMID:30545405 |
|
NCBI chr 4:96,011,118...96,134,767
Ensembl chr 4:96,010,952...96,134,712
|
|
G |
Gnmt |
glycine N-methyltransferase |
increases expression |
ISO |
Vancomycin results in increased expression of GNMT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Golm1 |
golgi membrane protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of GOLM1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:4,995,925...5,044,329
Ensembl chr17:4,996,104...5,034,057
|
|
G |
Gpc3 |
glypican 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of GPC3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:131,868,983...132,236,837
Ensembl chr X:131,868,990...132,236,798
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of GPD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
|
|
G |
Gpm6a |
glycoprotein m6a |
increases expression |
ISO |
Vancomycin results in increased expression of GPM6A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:36,641,282...36,973,477
Ensembl chr16:36,641,284...36,973,475
|
|
G |
Gpm6b |
glycoprotein m6b |
decreases expression |
ISO |
Vancomycin results in decreased expression of GPM6B mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:28,057,788...28,204,409
Ensembl chr X:28,059,450...28,204,211
|
|
G |
Gpsm3 |
G-protein signaling modulator 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of GPSM3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:4,157,123...4,158,984
Ensembl chr20:4,157,123...4,159,035
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression multiple interactions |
ISO |
Vancomycin results in increased expression of GPT mRNA [Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased activity of GPT protein] |
CTD |
PMID:18930951 PMID:34979169 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GPX1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx6 |
glutathione peroxidase 6 |
increases expression |
ISO |
Vancomycin results in increased expression of GPX6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:43,408,472...43,416,091
Ensembl chr17:43,408,472...43,416,091
|
|
G |
Grn |
granulin precursor |
decreases expression |
ISO |
Vancomycin results in decreased expression of GRN mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
ISO |
Vancomycin results in increased expression of GSTA2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTA3 mRNA |
CTD |
PMID:30545405 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
increases expression |
ISO |
Vancomycin results in increased expression of GSTK1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA |
CTD |
PMID:30545405 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
increases expression |
ISO |
Vancomycin results in increased expression of GSTZ1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of GUCY1A1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
Gusb |
glucuronidase, beta |
decreases expression |
ISO |
Vancomycin results in decreased expression of GUSB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:26,701,191...26,714,718
Ensembl chr12:26,697,951...26,726,905
|
|
G |
Gys2 |
glycogen synthase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of GYS2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
|
|
G |
H2ax |
H2A.X variant histone |
decreases expression |
ISO |
Vancomycin results in decreased expression of H2AX mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
decreases expression |
ISO |
Vancomycin results in decreased expression of H6PD mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
|
|
G |
Haao |
3-hydroxyanthranilate 3,4-dioxygenase |
increases expression |
ISO |
Vancomycin results in increased expression of HAAO mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:10,845,235...10,864,863
Ensembl chr 6:10,845,771...10,864,877
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of HAO2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
decreases expression increases expression multiple interactions |
ISO EXP |
Vancomycin results in decreased expression of HAVCR1 mRNA Vancomycin results in increased expression of HAVCR1 mRNA JBP 485 inhibits the reaction [Vancomycin results in increased expression of HAVCR1 mRNA] |
CTD |
PMID:18289764 PMID:18930951 PMID:29964132 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Herpud1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
increases expression |
ISO |
Vancomycin results in increased expression of HERPUD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
|
|
G |
Hexb |
hexosaminidase subunit beta |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of HEXB protein |
CTD |
PMID:30545405 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Hgd |
homogentisate 1, 2-dioxygenase |
increases expression |
ISO |
Vancomycin results in increased expression of HGD mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:63,086,750...63,138,325
Ensembl chr11:63,086,752...63,138,323
|
|
G |
Hibadh |
3-hydroxyisobutyrate dehydrogenase |
increases expression |
ISO |
Vancomycin results in increased expression of HIBADH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:81,649,180...81,747,244
Ensembl chr 4:81,649,175...81,780,617
|
|
G |
Hist1h4b |
histone cluster 1 H4 family member B |
increases expression |
ISO |
Vancomycin results in increased expression of H4C9 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
|
|
G |
Hlf |
HLF transcription factor, PAR bZIP family member |
increases expression |
ISO |
Vancomycin results in increased expression of HLF mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935
|
|
G |
Hmga1 |
high mobility group AT-hook 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of HMGA1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of HMGB2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression increases expression |
ISO EXP |
Vancomycin results in decreased expression of HMOX1 mRNA Vancomycin results in increased expression of HMOX1 mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
increases expression |
ISO |
Vancomycin results in increased expression of HNF4A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hnmt |
histamine N-methyltransferase |
increases expression |
ISO |
Vancomycin results in increased expression of HNMT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of HNRNPA1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hnrnph2 |
heterogeneous nuclear ribonucleoprotein H2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HNRNPH2 protein |
CTD |
PMID:30545405 |
|
NCBI chr X:97,780,890...97,786,846
Ensembl chr X:97,780,785...97,787,041
|
|
G |
Hp |
haptoglobin |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HP protein |
CTD |
PMID:30545405 |
|
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hpd |
4-hydroxyphenylpyruvate dioxygenase |
increases expression |
ISO |
Vancomycin results in increased expression of HPD mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:33,381,397...33,392,750
Ensembl chr12:33,381,231...33,392,766
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
increases expression |
ISO |
Vancomycin results in increased expression of HPGD mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Hsd17b14 |
hydroxysteroid (17-beta) dehydrogenase 14 |
increases expression |
ISO |
Vancomycin results in increased expression of HSD17B14 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:96,029,290...96,039,088
Ensembl chr 1:96,029,284...96,039,883
|
|
G |
Hsd3b3 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 |
increases expression |
ISO |
Vancomycin results in increased expression of HSD3B3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:186,138,044...186,144,024
Ensembl chr 2:186,138,044...186,144,033
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of HSPB1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ICAM1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id4 |
inhibitor of DNA binding 4 |
increases expression |
ISO |
Vancomycin results in increased expression of ID4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
|
|
G |
Ier5 |
immediate early response 5 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IER5 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
|
|
G |
Ifi27 |
interferon, alpha-inducible protein 27 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IFI27 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
|
|
G |
Ifi35 |
interferon-induced protein 35 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IFI35 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
|
|
G |
Ifi44 |
interferon-induced protein 44 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IFI44 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
|
|
G |
Ifi44l |
interferon-induced protein 44-like |
decreases expression |
ISO |
Vancomycin results in decreased expression of IFI44L mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IFIH1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IFIT2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IFIT3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IFITM1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IFITM3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IFNGR1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
affects expression increases expression |
EXP ISO |
Vancomycin affects the expression of IGFBP1 mRNA Vancomycin results in increased expression of IGFBP1 mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
increases expression |
ISO |
Vancomycin results in increased expression of IGFBP5 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Igkc |
immunoglobulin kappa constant |
affects expression |
EXP |
Vancomycin affects the expression of IGKC mRNA |
CTD |
PMID:18289764 |
|
|
|
G |
Igsf11 |
immunoglobulin superfamily, member 11 |
increases expression |
ISO |
Vancomycin results in increased expression of IGSF11 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:61,733,139...61,884,059
Ensembl chr11:61,733,144...61,868,348
|
|
G |
Igsf8 |
immunoglobulin superfamily, member 8 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IGSF8 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:84,770,348...84,781,534
Ensembl chr13:84,770,279...84,778,576
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Vancomycin promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] |
CTD |
PMID:16939481 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased secretion of IL18 protein] |
CTD |
PMID:35390362 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of and results in increased secretion of IL1B protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of IL1B mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of IL1B protein]] |
CTD |
PMID:32068018 PMID:35390362 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein] |
CTD |
PMID:31442584 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
decreases expression |
ISO |
Vancomycin results in decreased expression of IL6ST mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
increases expression |
ISO |
Vancomycin results in increased expression of INMT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
|
|
G |
Insig1 |
insulin induced gene 1 |
increases expression |
ISO |
Vancomycin results in increased expression of INSIG1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Insrr |
insulin receptor-related receptor |
increases expression |
ISO |
Vancomycin results in increased expression of INSRR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:173,255,335...173,274,800
Ensembl chr 2:173,255,414...173,274,800
|
|
G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IQGAP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
|
|
G |
Iqsec2 |
IQ motif and Sec7 domain ArfGEF 2 |
increases expression |
ISO |
Vancomycin results in increased expression of IQSEC2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:21,254,799...21,337,179
Ensembl chr X:21,254,914...21,336,584
|
|
G |
Irf1 |
interferon regulatory factor 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IRF1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irf8 |
interferon regulatory factor 8 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IRF8 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:48,790,483...48,812,363
Ensembl chr19:48,790,588...48,811,829
|
|
G |
Irf9 |
interferon regulatory factor 9 |
decreases expression |
ISO |
Vancomycin results in decreased expression of IRF9 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
|
|
G |
Irgm |
immunity-related GTPase M |
decreases expression |
ISO |
Vancomycin results in decreased expression of IRGM mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
|
|
G |
Irs1 |
insulin receptor substrate 1 |
increases expression |
ISO |
Vancomycin results in increased expression of IRS1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Itga3 |
integrin subunit alpha 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ITGA3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
|
|
G |
Itgb1 |
integrin subunit beta 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of ITGB1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Itpr2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
increases expression |
ISO |
Vancomycin results in increased expression of ITPR2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:179,028,594...179,434,657
Ensembl chr 4:179,027,281...179,404,164
|
|
G |
Ivd |
isovaleryl-CoA dehydrogenase |
increases expression |
ISO |
Vancomycin results in increased expression of IVD mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:105,851,710...105,872,144
Ensembl chr 3:105,851,683...105,872,575
|
|
G |
Jpt1 |
Jupiter microtubule associated homolog 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of JPT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:100,744,468...100,762,504
Ensembl chr10:100,686,797...100,784,513
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
affects expression |
EXP |
Vancomycin affects the expression of JUN mRNA |
CTD |
PMID:18289764 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kank3 |
KN motif and ankyrin repeat domains 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of KANK3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:14,594,358...14,607,675
Ensembl chr 7:14,594,422...14,607,675
|
|
G |
Kbtbd11 |
kelch repeat and BTB domain containing 11 |
increases expression |
ISO |
Vancomycin results in increased expression of KBTBD11 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:74,618,291...74,638,010
Ensembl chr16:74,615,792...74,637,736
|
|
G |
Kcnip2 |
potassium voltage-gated channel interacting protein 2 |
increases expression |
ISO |
Vancomycin results in increased expression of KCNIP2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:244,641,147...244,664,939
Ensembl chr 1:244,641,150...244,664,874
|
|
G |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
increases expression |
ISO |
Vancomycin results in increased expression of KCNJ1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:30,779,883...30,808,607
Ensembl chr 8:30,753,617...30,813,796
|
|
G |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
increases expression |
ISO |
Vancomycin results in increased expression of KCNJ15 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952
|
|
G |
Kcnk1 |
potassium two pore domain channel subfamily K member 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of KCNK1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:53,959,411...53,997,726
Ensembl chr19:53,959,657...53,997,724
|
|
G |
Kcnk5 |
potassium two pore domain channel subfamily K member 5 |
increases expression |
ISO |
Vancomycin results in increased expression of KCNK5 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:4,122,442...4,164,718
Ensembl chr15:4,122,442...4,164,718
|
|
G |
Kctd1 |
potassium channel tetramerization domain containing 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of KCTD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:6,122,390...6,316,434
Ensembl chr18:6,122,390...6,317,393
|
|
G |
Khk |
ketohexokinase |
increases expression |
ISO |
Vancomycin results in increased expression of KHK mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:25,445,298...25,455,834
Ensembl chr 6:25,445,300...25,455,717
|
|
G |
Kif21a |
kinesin family member 21A |
increases expression |
ISO |
Vancomycin results in increased expression of KIF21A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:122,062,523...122,179,051
Ensembl chr 7:122,062,537...122,178,999
|
|
G |
Kif22 |
kinesin family member 22 |
decreases expression |
ISO |
Vancomycin results in decreased expression of KIF22 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401
|
|
G |
Kl |
Klotho |
increases expression |
ISO |
Vancomycin results in increased expression of KL mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
|
|
G |
Klf12 |
KLF transcription factor 12 |
increases expression |
ISO |
Vancomycin results in increased expression of KLF12 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056
|
|
G |
Klf15 |
KLF transcription factor 15 |
increases expression |
ISO |
Vancomycin results in increased expression of KLF15 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
|
|
G |
Klf6 |
KLF transcription factor 6 |
decreases expression |
ISO |
Vancomycin results in decreased expression of KLF6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
|
|
G |
Klk1b3 |
kallikrein 1-related peptidase B3 |
decreases expression |
EXP |
Vancomycin results in decreased expression of NGFG mRNA |
CTD |
PMID:18289764 |
|
NCBI chr 1:94,709,105...94,713,308
Ensembl chr 1:94,709,105...94,713,308
|
|
G |
Kmo |
kynurenine 3-monooxygenase |
increases expression |
ISO |
Vancomycin results in increased expression of KMO mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
|
|
G |
Kng2 |
kininogen 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAP1 protein |
CTD |
PMID:30545405 |
|
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of KPNA2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
|
|
G |
Kpnb1 |
karyopherin subunit beta 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of KPNB1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
|
|
G |
Krt16 |
keratin 16 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of KRT16 protein |
CTD |
PMID:30545405 |
|
NCBI chr10:85,168,357...85,171,744
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt18 |
keratin 18 |
decreases expression |
ISO |
Vancomycin results in decreased expression of KRT18 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Krt7 |
keratin 7 |
decreases expression |
ISO |
Vancomycin results in decreased expression of KRT7 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:132,528,863...132,545,052
Ensembl chr 7:132,528,895...132,545,052
|
|
G |
Krt8 |
keratin 8 |
decreases expression |
ISO |
Vancomycin results in decreased expression of KRT8 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Kyat3 |
kynurenine aminotransferase 3 |
increases expression |
ISO |
Vancomycin results in increased expression of KYAT3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:231,701,881...231,747,462
Ensembl chr 2:231,701,963...231,747,227
|
|
G |
Kynu |
kynureninase |
increases expression |
ISO |
Vancomycin results in increased expression of KYNU mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
|
|
G |
L2hgdh |
L-2-hydroxyglutarate dehydrogenase |
increases expression |
ISO |
Vancomycin results in increased expression of L2HGDH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:88,164,429...88,205,585
Ensembl chr 6:88,164,440...88,205,578
|
|
G |
Lactb2 |
lactamase, beta 2 |
increases expression |
ISO |
Vancomycin results in increased expression of LACTB2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of LAMC2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:65,284,664...65,344,200
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Laptm5 |
lysosomal protein transmembrane 5 |
decreases expression |
ISO |
Vancomycin results in decreased expression of LAPTM5 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression |
EXP |
Vancomycin results in increased expression of LCN2 mRNA |
CTD |
PMID:18289764 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lcp1 |
lymphocyte cytosolic protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of LCP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of LEP mRNA |
CTD |
PMID:34979169 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lgals1 |
galectin 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of LGALS1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
|
|
G |
Lgals3 |
galectin 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of LGALS3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lgals3bp |
galectin 3 binding protein |
decreases expression |
ISO |
Vancomycin results in decreased expression of LGALS3BP mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
|
|
G |
Lgals9 |
galectin 9 |
decreases expression |
ISO |
Vancomycin results in decreased expression of LGALS9 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
|
|
G |
Lhfpl2 |
LHFPL tetraspan subfamily member 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of LHFPL2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:25,281,771...25,428,128
Ensembl chr 2:25,281,901...25,427,950
|
|
G |
Lhx1 |
LIM homeobox 1 |
increases expression |
ISO |
Vancomycin results in increased expression of LHX1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:69,396,829...69,403,617
Ensembl chr10:69,396,829...69,403,617
|
|
G |
Lin7a |
lin-7 homolog A, crumbs cell polarity complex component |
increases expression |
ISO |
Vancomycin results in increased expression of LIN7A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
|
|
G |
Litaf |
lipopolysaccharide-induced TNF factor |
decreases expression |
ISO |
Vancomycin results in decreased expression of LITAF mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
|
|
G |
Lmna |
lamin A/C |
decreases expression |
ISO |
Vancomycin results in decreased expression of LMNA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
|
|
G |
Lmo7 |
LIM domain 7 |
decreases expression |
ISO |
Vancomycin results in decreased expression of LMO7 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:78,567,029...78,769,833
Ensembl chr15:78,567,023...78,769,783
|
|
G |
Loxl1 |
lysyl oxidase-like 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of LOXL1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:58,692,592...58,716,356
Ensembl chr 8:58,692,593...58,716,356
|
|
G |
Lpar3 |
lysophosphatidic acid receptor 3 |
increases expression |
ISO |
Vancomycin results in increased expression of LPAR3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:235,125,234...235,193,916
Ensembl chr 2:235,149,065...235,193,357
|
|
G |
Lpin1 |
lipin 1 |
increases expression |
ISO |
Vancomycin results in increased expression of LPIN1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Lpl |
lipoprotein lipase |
increases expression |
ISO |
Vancomycin results in increased expression of LPL mRNA |
CTD |
PMID:18930951 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Lrpap1 |
LDL receptor related protein associated protein 1 |
increases expression |
ISO |
Vancomycin results in increased expression of LRPAP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:75,651,371...75,663,380
Ensembl chr14:75,651,376...75,665,414
|
|
G |
Lrrc19 |
leucine rich repeat containing 19 |
increases expression |
ISO |
Vancomycin results in increased expression of LRRC19 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:109,497,503...109,502,488
Ensembl chr 5:109,497,121...109,507,938
|
|
G |
Ly6e |
lymphocyte antigen 6 family member E |
decreases expression |
ISO |
Vancomycin results in decreased expression of LY6E mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
|
|
G |
Lyn |
LYN proto-oncogene, Src family tyrosine kinase |
decreases expression |
ISO |
Vancomycin results in decreased expression of LYN mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:16,639,512...16,755,501
Ensembl chr 5:16,639,466...16,756,868
|
|
G |
Lyplal1 |
lysophospholipase-like 1 |
increases expression |
ISO |
Vancomycin results in increased expression of LYPLAL1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:97,626,451...97,657,901
Ensembl chr13:97,626,451...97,657,867
|
|
G |
Lyz2 |
lysozyme 2 |
decreases expression multiple interactions |
ISO EXP |
Vancomycin results in decreased expression of LYZ2 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein |
CTD |
PMID:18930951 PMID:30545405 |
|
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
|
|
G |
Mad2l1 |
mitotic arrest deficient 2 like 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MAD2L1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
|
|
G |
Mad2l2 |
mitotic arrest deficient 2 like 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MAD2L2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:158,563,545...158,576,698
Ensembl chr 5:158,563,567...158,576,693
|
|
G |
Mal2 |
mal, T-cell differentiation protein 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MAL2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:85,900,453...85,933,433
Ensembl chr 7:85,900,453...85,933,429
|
|
G |
Map7 |
microtubule-associated protein 7 |
increases expression |
ISO |
Vancomycin results in increased expression of MAP7 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:14,910,433...15,037,574
Ensembl chr 1:14,910,551...15,037,574
|
|
G |
Map7d1 |
MAP7 domain containing 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MAP7D1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:138,527,944...138,552,537
Ensembl chr 5:138,527,401...138,552,499
|
|
G |
Mapk13 |
mitogen activated protein kinase 13 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MAPK13 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:6,835,277...6,845,500
Ensembl chr20:6,835,320...6,844,222
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAPK3 protein |
CTD |
PMID:30545405 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk4 |
mitogen-activated protein kinase 4 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MAPK4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:67,512,805...67,661,271
Ensembl chr18:67,512,807...67,661,842
|
|
G |
Mapt |
microtubule-associated protein tau |
increases expression |
ISO |
Vancomycin results in increased expression of MAPT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Marchf10 |
membrane associated ring-CH-type finger 10 |
increases expression |
ISO |
Vancomycin results in increased expression of MARCHF10 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:90,332,783...90,423,109
Ensembl chr10:90,332,784...90,421,588
|
|
G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
decreases expression |
ISO |
Vancomycin results in decreased expression of MARCKS mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
|
|
G |
Marcksl1 |
MARCKS-like 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MARCKSL1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
|
|
G |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MAST4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:33,893,241...34,483,600
Ensembl chr 2:33,894,436...34,483,723
|
|
G |
Mccc1 |
methylcrotonyl-CoA carboxylase subunit 1 |
increases expression |
ISO |
Vancomycin results in increased expression of MCCC1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:118,799,147...118,851,181
Ensembl chr 2:118,799,150...118,851,222
|
|
G |
Mccc2 |
methylcrotonyl-CoA carboxylase subunit 2 |
increases expression |
ISO |
Vancomycin results in increased expression of MCCC2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:31,304,927...31,375,978
Ensembl chr 2:31,304,932...31,375,972
|
|
G |
Mcm4 |
minichromosome maintenance complex component 4 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MCM4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
|
|
G |
Mcm5 |
minichromosome maintenance complex component 5 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MCM5 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
|
|
G |
Mcm7 |
minichromosome maintenance complex component 7 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MCM7 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
|
|
G |
Mdh1 |
malate dehydrogenase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of MDH1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
|
|
G |
Mep1b |
meprin A subunit beta |
increases expression |
ISO |
Vancomycin results in increased expression of MEP1B mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:12,366,126...12,392,840
Ensembl chr18:12,365,289...12,392,840
|
|
G |
Mfge8 |
milk fat globule EGF and factor V/VIII domain containing |
decreases expression |
ISO |
Vancomycin results in decreased expression of MFGE8 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:133,064,665...133,080,073
|
|
G |
Mfsd2a |
MFSD2 lysolipid transporter A, lysophospholipid |
increases expression |
ISO |
Vancomycin results in increased expression of MFSD2A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
|
|
G |
Mgam |
maltase-glucoamylase |
increases expression |
ISO |
Vancomycin results in increased expression of MGAM mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:69,441,626...69,602,068
Ensembl chr 4:69,446,150...69,692,715
|
|
G |
Mgat3 |
beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
increases expression |
ISO |
Vancomycin results in increased expression of MGAT3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:111,708,353...111,761,825
Ensembl chr 7:111,675,730...111,762,026
|
|
G |
Mgll |
monoglyceride lipase |
increases expression |
ISO |
Vancomycin results in increased expression of MGLL mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:121,192,187...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Mgp |
matrix Gla protein |
increases expression decreases expression |
EXP ISO |
Vancomycin results in increased expression of MGP mRNA Vancomycin results in decreased expression of MGP mRNA |
CTD |
PMID:18289764 PMID:18930951 |
|
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
|
|
G |
Miox |
myo-inositol oxygenase |
increases expression |
ISO |
Vancomycin results in increased expression of MIOX mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:120,405,031...120,407,529
Ensembl chr 7:120,405,031...120,407,537
|
|
G |
Mlxip |
MLX interacting protein |
multiple interactions |
ISO |
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased expression of MLXIP mRNA] |
CTD |
PMID:34979169 |
|
NCBI chr12:33,128,524...33,192,300
Ensembl chr12:33,128,520...33,192,374
|
|
G |
Mmut |
methylmalonyl-CoA mutase |
increases expression |
ISO |
Vancomycin results in increased expression of MMUT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046
|
|
G |
Morf4l2 |
mortality factor 4 like 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MORF4L2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:100,082,562...100,093,658
Ensembl chr X:100,082,404...100,093,728
|
|
G |
Mpeg1 |
macrophage expressed 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MPEG1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:209,452,176...209,456,692
Ensembl chr 1:209,452,133...209,458,855
|
|
G |
Mpv17l |
MPV17 mitochondrial inner membrane protein like |
increases expression |
ISO |
Vancomycin results in increased expression of MPV17L mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:1,988,451...2,025,300
Ensembl chr10:1,988,136...2,007,649
|
|
G |
Mr1 |
major histocompatibility complex, class I-related |
affects expression |
ISO |
Vancomycin affects the expression of MR1 mRNA |
CTD |
PMID:25811541 |
|
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
|
|
G |
Mrtfb |
myocardin related transcription factor B |
decreases expression |
ISO |
Vancomycin results in decreased expression of MRTFB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:1,116,315...1,278,106
Ensembl chr10:1,116,310...1,277,897
|
|
G |
Msn |
moesin |
decreases expression |
ISO |
Vancomycin results in decreased expression of MSN mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
EXP |
Vancomycin results in increased expression of MT1A mRNA |
CTD |
PMID:18289764 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
decreases expression |
ISO |
Vancomycin results in decreased expression of MT2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mthfd1 |
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of MTHFD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 6:94,977,862...95,045,375
Ensembl chr 6:94,977,862...95,045,372
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases expression |
ISO |
Vancomycin results in increased expression of MTOR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
increases expression |
ISO |
Vancomycin results in increased expression of MTTP mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Muc1 |
mucin 1, cell surface associated |
decreases expression |
ISO |
Vancomycin results in decreased expression of MUC1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:174,635,559...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Mvp |
major vault protein |
decreases expression |
ISO |
Vancomycin results in decreased expression of MVP mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:181,594,734...181,622,336
Ensembl chr 1:181,594,734...181,622,380
|
|
G |
Myadm |
myeloid-associated differentiation marker |
decreases expression |
ISO |
Vancomycin results in decreased expression of MYADM mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
decreases expression multiple interactions |
ISO |
Vancomycin results in decreased expression of MYD88 mRNA [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 protein] |
CTD |
PMID:18930951 PMID:35390362 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Myef2 |
myelin expression factor 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MYEF2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:112,338,241...112,374,122
Ensembl chr 3:112,338,241...112,374,181
|
|
G |
Myh14 |
myosin heavy chain 14 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MYH14 protein |
CTD |
PMID:30545405 |
|
NCBI chr 1:95,096,266...95,158,861
Ensembl chr 1:95,096,266...95,158,836
|
|
G |
Myh9 |
myosin, heavy chain 9 |
decreases expression |
ISO |
Vancomycin results in decreased expression of MYH9 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
|
|
G |
Nap1l5 |
nucleosome assembly protein 1-like 5 |
increases expression |
ISO |
Vancomycin results in increased expression of NAP1L5 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:88,022,670...88,024,988
Ensembl chr 4:88,022,569...88,024,654
|
|
G |
Nasp |
nuclear autoantigenic sperm protein |
decreases expression |
ISO |
Vancomycin results in decreased expression of NASP mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
|
|
G |
Nat8 |
N-acetyltransferase 8 |
increases expression |
ISO |
Vancomycin results in increased expression of NAT8 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:118,279,521...118,284,671
Ensembl chr 4:118,270,954...118,281,763
|
|
G |
Nat8f1 |
N-acetyltransferase 8 (GCN5-related) family member 1 |
increases expression |
ISO |
Vancomycin results in increased expression of NAT8F1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:118,336,208...118,342,923
Ensembl chr 4:118,332,862...118,344,035
|
|
G |
Nat8f3 |
N-acetyltransferase 8 (GCN5-related) family member 3 |
increases expression |
ISO |
Vancomycin results in increased expression of NAT8F3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:118,241,792...118,246,010
Ensembl chr 4:118,239,304...118,285,500
|
|
G |
Ndufa13 |
NADH:ubiquinone oxidoreductase subunit A13 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFA13 protein |
CTD |
PMID:30545405 |
|
NCBI chr16:19,526,633...19,533,567
Ensembl chr16:19,526,565...19,535,726
|
|
G |
Ndufab1 |
NADH:ubiquinone oxidoreductase subunit AB1 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 1:176,644,696...176,658,131
Ensembl chr 1:176,644,703...176,658,099
|
|
G |
Ndufs4 |
NADH:ubiquinone oxidoreductase subunit S4 |
increases expression |
ISO |
Vancomycin results in increased expression of NDUFS4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:45,951,327...46,061,829
Ensembl chr 2:45,951,313...46,061,846
|
|
G |
Nectin2 |
nectin cell adhesion molecule 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of NECTIN2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:79,372,123...79,407,379
Ensembl chr 1:79,372,119...79,407,360
|
|
G |
Nedd4 |
NEDD4 E3 ubiquitin protein ligase |
decreases expression |
ISO |
Vancomycin results in decreased expression of NEDD4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:73,384,095...73,468,951
Ensembl chr 8:73,383,695...73,468,951
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of NFKB1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbie |
NFKB inhibitor epsilon |
decreases expression |
ISO |
Vancomycin results in decreased expression of NFKBIE mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
|
|
G |
Nfkbiz |
NFKB inhibitor zeta |
decreases expression |
ISO |
Vancomycin results in decreased expression of NFKBIZ mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:44,782,676...44,810,723
Ensembl chr11:44,782,676...44,810,723
|
|
G |
Nherf4 |
NHERF family PDZ scaffold protein 4 |
increases expression |
ISO |
Vancomycin results in increased expression of NHERF4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:44,584,390...44,588,838
Ensembl chr 8:44,584,390...44,588,860
|
|
G |
Niban1 |
niban apoptosis regulator 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of NIBAN1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729
|
|
G |
Nid1 |
nidogen 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of NID1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:86,085,046...86,158,277
Ensembl chr17:86,085,077...86,158,267
|
|
G |
Nipsnap1 |
nipsnap homolog 1 |
increases expression |
ISO |
Vancomycin results in increased expression of NIPSNAP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:79,734,234...79,758,101
Ensembl chr14:79,734,209...79,758,098
|
|
G |
Nipsnap3b |
nipsnap homolog 3B |
decreases expression |
ISO |
Vancomycin results in decreased expression of NIPSNAP3A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:67,637,644...67,669,698
Ensembl chr 5:67,614,036...67,669,700
|
|
G |
Nit2 |
nitrilase family, member 2 |
increases expression |
ISO |
Vancomycin results in increased expression of NIT2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:43,363,839...43,378,713
Ensembl chr11:43,363,985...43,375,024
|
|
G |
Nlrp6 |
NLR family, pyrin domain containing 6 |
increases expression |
ISO |
Vancomycin results in increased expression of NLRP6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:196,004,854...196,011,615
Ensembl chr 1:196,004,953...196,011,113
|
|
G |
Nmi |
N-myc (and STAT) interactor |
decreases expression |
ISO |
Vancomycin results in decreased expression of NMI mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:36,415,607...36,439,716
Ensembl chr 3:36,415,607...36,439,498
|
|
G |
Nnt |
nicotinamide nucleotide transhydrogenase |
increases expression |
ISO |
Vancomycin results in increased expression of NNT mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
[Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of NOS2 mRNA]] |
CTD |
PMID:32068018 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nox4 |
NADPH oxidase 4 |
increases expression |
ISO |
Vancomycin results in increased expression of NOX4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Npc1l1 |
NPC1 like intracellular cholesterol transporter 1 |
multiple interactions |
ISO |
[Vancomycin co-treated with Imipenem] results in decreased expression of NPC1L1 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
|
|
G |
Npc2 |
NPC intracellular cholesterol transporter 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of NPC2 protein |
CTD |
PMID:30545405 |
|
NCBI chr 6:104,397,239...104,418,161
Ensembl chr 6:104,378,644...104,418,155
|
|
G |
Npdc1 |
neural proliferation, differentiation and control, 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of NPDC1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:8,220,446...8,226,446
Ensembl chr 3:8,213,663...8,226,866
|
|
G |
Nphs2 |
NPHS2 stomatin family member, podocin |
increases expression |
ISO |
Vancomycin results in increased expression of NPHS2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:68,448,720...68,461,312
Ensembl chr13:68,448,926...68,461,313
|
|
G |
Npm1 |
nucleophosmin 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of NPM1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
|
|
G |
Npy |
neuropeptide Y |
increases expression |
ISO |
Vancomycin results in increased expression of NPY mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
multiple interactions |
ISO |
[Vancomycin co-treated with Imipenem] results in increased expression of NR0B2 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
increases expression |
ISO |
Vancomycin results in increased expression of NR1D1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
|
|
G |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
multiple interactions |
ISO |
[Vancomycin co-treated with Imipenem] results in increased expression of NR5A2 mRNA |
CTD |
PMID:24657338 |
|
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
decreases expression |
ISO |
Vancomycin results in decreased expression of NRAS mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
|
|
G |
Nucb2 |
nucleobindin 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of NUCB2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:170,750,830...170,787,356
Ensembl chr 1:170,750,877...170,787,353
|
|
G |
Nudcd1 |
NudC domain containing 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of NUDCD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:75,550,650...75,595,976
Ensembl chr 7:75,550,346...75,595,900
|
|
G |
Nudt21 |
nudix hydrolase 21 |
decreases expression |
ISO |
Vancomycin results in decreased expression of NUDT21 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr19:10,974,800...10,993,841
Ensembl chr19:10,974,241...10,991,682
|
|
G |
Nup62 |
nucleoporin 62 |
decreases expression |
ISO |
Vancomycin results in decreased expression of NUP62 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:95,298,995...95,314,902
Ensembl chr 1:95,295,526...95,315,174
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
decreases expression |
ISO |
Vancomycin results in decreased expression of NUPR1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:181,213,292...181,215,327
|
|
G |
Oat |
ornithine aminotransferase |
decreases expression |
EXP |
Vancomycin results in decreased expression of OAT mRNA |
CTD |
PMID:18289764 |
|
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
|
|
G |
Ocln |
occludin |
multiple interactions |
ISO |
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein] |
CTD |
PMID:35390362 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Olfm3 |
olfactomedin 3 |
increases expression |
ISO |
Vancomycin results in increased expression of OLFM3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:202,729,610...202,952,120
Ensembl chr 2:202,729,936...202,952,112
|
|
G |
Olfml3 |
olfactomedin-like 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of OLFML3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:191,244,221...191,247,050
|
|
G |
Osbpl1a |
oxysterol binding protein-like 1A |
increases expression |
ISO |
Vancomycin results in increased expression of OSBPL1A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585
|
|
G |
Osmr |
oncostatin M receptor |
decreases expression |
ISO |
Vancomycin results in decreased expression of OSMR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262
|
|
G |
Ostf1 |
osteoclast stimulating factor 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of OSTF1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:216,002,037...216,049,250
Ensembl chr 1:216,002,044...216,049,221
|
|
G |
Oxct1 |
3-oxoacid CoA transferase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of OXCT1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:53,236,370...53,384,715
Ensembl chr 2:53,236,368...53,384,714
|
|
G |
P3h2 |
prolyl 3-hydroxylase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of P3H2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:74,634,267...74,775,422
Ensembl chr11:74,634,267...74,775,421
|
|
G |
P4ha2 |
prolyl 4-hydroxylase subunit alpha 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of P4HA2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:38,243,047...38,271,989
Ensembl chr10:38,243,139...38,287,314
|
|
G |
Pafah1b3 |
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PAFAH1B3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:80,881,263...80,883,789
Ensembl chr 1:80,881,309...80,883,893
|
|
G |
Pah |
phenylalanine hydroxylase |
increases expression |
ISO |
Vancomycin results in increased expression of PAH mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
|
|
G |
Pank1 |
pantothenate kinase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of PANK1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:232,324,718...232,395,445
Ensembl chr 1:232,328,430...232,396,829
|
|
G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of PAPSS2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases expression |
EXP |
1,5-dihydroxyisoquinoline inhibits the reaction [Vancomycin results in increased expression of PARP1 protein] |
CTD |
PMID:19833176 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Parp12 |
poly (ADP-ribose) polymerase family, member 12 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PARP12 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:67,826,548...67,885,356
Ensembl chr 4:67,839,237...67,883,685
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PARP14 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
|
|
G |
Parp3 |
poly (ADP-ribose) polymerase family, member 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PARP3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:107,111,010...107,117,073
Ensembl chr 8:107,111,012...107,116,782
|
|
G |
Parp8 |
poly (ADP-ribose) polymerase family, member 8 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PARP8 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:48,679,405...48,848,700
Ensembl chr 2:48,679,436...48,849,253
|
|
G |
Parp9 |
poly (ADP-ribose) polymerase family, member 9 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PARP9 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr11:64,780,977...64,814,995
Ensembl chr11:64,780,981...64,815,455
|
|
G |
Pc |
pyruvate carboxylase |
increases expression |
ISO |
Vancomycin results in increased expression of PCX mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
|
|
G |
Pcbd1 |
pterin-4 alpha-carbinolamine dehydratase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of PCBD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:29,037,545...29,044,322
Ensembl chr20:28,953,864...29,044,292 Ensembl chr20:28,953,864...29,044,292
|
|
G |
Pcca |
propionyl-CoA carboxylase subunit alpha |
increases expression |
ISO |
Vancomycin results in increased expression of PCCA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:99,627,955...99,969,555
Ensembl chr15:99,627,982...99,968,266
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of PCK1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
Vancomycin results in decreased expression of PCNA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pcolce |
procollagen C-endopeptidase enhancer |
decreases expression |
ISO |
Vancomycin results in decreased expression of PCOLCE mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
|
|
G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
increases expression |
ISO |
Vancomycin results in increased expression of PCSK6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:119,428,978...119,627,626
Ensembl chr 1:119,429,265...119,627,596
|
|
G |
Pcyt2 |
phosphate cytidylyltransferase 2, ethanolamine |
increases expression |
ISO |
Vancomycin results in increased expression of PCYT2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:105,888,769...105,896,182
Ensembl chr10:105,888,775...105,896,172
|
|
G |
Pde1a |
phosphodiesterase 1A |
increases expression |
ISO |
Vancomycin results in increased expression of PDE1A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
|
|
G |
Pde9a |
phosphodiesterase 9A |
increases expression |
ISO |
Vancomycin results in increased expression of PDE9A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:9,469,809...9,562,949
Ensembl chr20:9,469,848...9,562,948
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
decreases expression |
ISO |
Vancomycin results in decreased expression of PDGFA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
decreases expression |
ISO |
Vancomycin results in decreased expression of PDGFB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
decreases expression |
ISO |
Vancomycin results in decreased expression of PDGFRB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:54,500,002...54,538,843
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pdhb |
pyruvate dehydrogenase E1 subunit beta |
increases expression |
ISO |
Vancomycin results in increased expression of PDHB mRNA |
CTD |
PMID:18930951 |
|
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
|
|
G |
Pdk2 |
pyruvate dehydrogenase kinase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of PDK2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:79,972,550...79,987,074
Ensembl chr10:79,972,556...79,987,085
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PDK4 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pdlim1 |
PDZ and LIM domain 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PDLIM1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:239,042,372...239,091,074
Ensembl chr 1:239,042,385...239,091,076
|
|
G |
Pdpn |
podoplanin |
decreases expression |
ISO |
Vancomycin results in decreased expression of PDPN mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656
|
|
G |
Pdzd2 |
PDZ domain containing 2 |
increases expression |
ISO |
Vancomycin results in increased expression of PDZD2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:61,384,614...61,770,516
Ensembl chr 2:61,386,381...61,770,524
|
|
G |
Pea15 |
proliferation and apoptosis adaptor protein 15 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PEA15 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
|
|
G |
Pecr |
peroxisomal trans-2-enoyl-CoA reductase |
increases expression |
ISO |
Vancomycin results in increased expression of PECR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:73,897,877...73,926,511
Ensembl chr 9:73,897,880...73,926,511
|
|
G |
Pfkm |
phosphofructokinase, muscle |
increases expression |
ISO |
Vancomycin results in increased expression of PFKM mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:129,221,679...129,259,192
Ensembl chr 7:129,221,653...129,259,192
|
|
G |
Pfn1 |
profilin 1 |
decreases expression multiple interactions |
ISO EXP |
Vancomycin results in decreased expression of PFN1 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PFN1 protein |
CTD |
PMID:18930951 PMID:30545405 |
|
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
|
|
G |
Pfn3 |
profilin 3 |
increases expression |
ISO |
Vancomycin results in increased expression of PFN3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:9,217,595...9,218,122
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PGAM1 protein |
CTD |
PMID:30545405 |
|
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
|
|
G |
Pgam2 |
phosphoglycerate mutase 2 |
increases expression |
ISO |
Vancomycin results in increased expression of PGAM2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:80,681,796...80,683,907
Ensembl chr14:80,681,776...80,683,940
|
|
G |
Pgap6 |
post-GPI attachment to proteins 6 |
increases expression |
ISO |
Vancomycin results in increased expression of PGAP6 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:15,138,918...15,151,581
Ensembl chr10:15,138,959...15,148,431
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
decreases expression |
ISO |
Vancomycin results in decreased expression of PGD mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Pgm1 |
phosphoglucomutase 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PGM1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
|
|
G |
Pim3 |
Pim-3 proto-oncogene, serine/threonine kinase |
increases expression |
ISO |
Vancomycin results in increased expression of PIM3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:119,953,377...119,956,587
Ensembl chr 7:119,953,175...119,956,587
|
|
G |
Pink1 |
PTEN induced kinase 1 |
increases expression |
ISO |
Vancomycin results in increased expression of PINK1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pip4k2a |
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha |
decreases expression |
ISO |
Vancomycin results in decreased expression of PIP4K2A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr17:81,496,669...81,668,180
Ensembl chr17:81,496,670...81,668,029
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
decreases expression |
ISO |
Vancomycin results in decreased expression of PLA2G4A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
decreases expression |
ISO |
Vancomycin results in decreased expression of PLA2G7 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
|
|
G |
Plac8 |
placenta associated 8 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PLAC8 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
|
|
G |
Plec |
plectin |
decreases expression |
ISO |
Vancomycin results in decreased expression of PLEC mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:107,887,764...107,949,100
Ensembl chr 7:107,887,764...107,945,467
|
|
G |
Plekha7 |
pleckstrin homology domain containing A7 |
increases expression |
ISO |
Vancomycin results in increased expression of PLEKHA7 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:170,364,524...170,547,843
Ensembl chr 1:170,365,135...170,547,775
|
|
G |
Plekhg2 |
pleckstrin homology and RhoGEF domain containing G2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PLEKHG2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:83,651,856...83,666,046
Ensembl chr 1:83,647,748...83,665,063
|
|
G |
Plin2 |
perilipin 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PLIN2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:101,156,643...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plp2 |
proteolipid protein 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PLP2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr X:14,834,249...14,837,648
Ensembl chr X:14,834,231...14,838,514
|
|
G |
Plscr1 |
phospholipid scramblase 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PLSCR1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:92,784,279...92,804,698
Ensembl chr 8:92,784,356...92,804,692
|
|
G |
Plscr3 |
phospholipid scramblase 3 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PLSCR3 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:54,566,556...54,573,240
Ensembl chr10:54,566,873...54,578,709
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PMAIP1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr18:59,986,187...59,990,174
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PMEPA1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:162,011,884...162,060,137
Ensembl chr 3:162,012,751...162,060,454
|
|
G |
Pmm2 |
phosphomannomutase 2 |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PMM2 protein |
CTD |
PMID:30545405 |
|
NCBI chr10:6,961,521...6,982,913
Ensembl chr10:6,961,709...6,983,098
|
|
G |
Pold1 |
DNA polymerase delta 1, catalytic subunit |
decreases expression |
ISO |
Vancomycin results in decreased expression of POLD1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
|
|
G |
Polr3e |
RNA polymerase III subunit E |
increases expression |
ISO |
Vancomycin results in increased expression of POLR3E mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:175,466,091...175,494,679
Ensembl chr 1:175,466,127...175,494,667
|
|
G |
Pon1 |
paraoxonase 1 |
decreases activity multiple interactions |
EXP |
Vancomycin results in decreased activity of PON1 protein zingerone affects the reaction [Vancomycin results in decreased activity of PON1 protein] |
CTD |
PMID:31454121 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
increases expression |
ISO |
Vancomycin results in increased expression of PPARA mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases expression |
ISO |
Vancomycin results in increased expression of PPARGC1A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppm1m |
protein phosphatase, Mg2+/Mn2+ dependent, 1M |
decreases expression |
ISO |
Vancomycin results in decreased expression of PPM1M mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 8:106,836,221...106,843,472
Ensembl chr 8:106,837,037...106,842,057
|
|
G |
Ppp1ca |
protein phosphatase 1 catalytic subunit alpha |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CA protein |
CTD |
PMID:30545405 |
|
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
|
|
G |
Ppp1cb |
protein phosphatase 1 catalytic subunit beta |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CB protein |
CTD |
PMID:30545405 |
|
NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
|
|
G |
Ppp1cc |
protein phosphatase 1 catalytic subunit gamma |
multiple interactions |
EXP |
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CC protein |
CTD |
PMID:30545405 |
|
NCBI chr12:34,383,072...34,400,553
Ensembl chr12:34,383,072...34,400,553
|
|
G |
Ppp1r14b |
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
decreases expression |
ISO |
Vancomycin results in decreased expression of PPP1R14B mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319
|
|
G |
Ppp1r16b |
protein phosphatase 1, regulatory subunit 16B |
increases expression |
ISO |
Vancomycin results in increased expression of PPP1R16B mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 3:147,323,652...147,419,658
Ensembl chr 3:147,324,126...147,418,937
|
|
G |
Ppp1r1a |
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
increases expression |
ISO |
Vancomycin results in increased expression of PPP1R1A mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 7:134,654,578...134,662,236
Ensembl chr 7:134,654,579...134,662,230
|
|
G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
increases expression |
ISO |
Vancomycin results in increased expression of PPP1R1B mRNA |
CTD |
PMID:18930951 |
|
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
|
|
G |
Pprc1 |
PPARG related coactivator 1 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PPRC1 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 1:244,901,985...244,918,587
Ensembl chr 1:244,902,179...244,918,587
|
|
G |
Prkaa2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
increases expression |
ISO |
Vancomycin results in increased expression of PRKAA2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
|
|
G |
Prkcz |
protein kinase C, zeta |
increases expression |
ISO |
Vancomycin results in increased expression of PRKCZ mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
|
|
G |
Prlr |
prolactin receptor |
increases expression |
ISO |
Vancomycin results in increased expression of PRLR mRNA |
CTD |
PMID:18930951 |
|
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
|
|
G |
Prmt2 |
protein arginine methyltransferase 2 |
decreases expression |
ISO |
Vancomycin results in decreased expression of PRMT2 mRNA |
CTD |
PMID:18930951 |
|
NCBI chr20:12,394,748...12,420,643
Ensembl chr20:12,394,798...12,420,643
|
|
|